During this fireside chat webcast, we welcome Delcath Systems, ticker symbol DCTH on the NASDAQ. Joining us today from the company is Gerard Michel, Delcath’s Chief Executive Officer. Also joining us today is Bill Maughan, Senior Research Analyst with Canaccord Genuity, whom I’ve had asked to moderate today’s fireside chat. Bill covers a wide array of cancer therapy companies at Canaccord Genuity, including Delcath.

This Fireside Chat was recorded during the Lytham Partners 2024 Investor Select Conference.